GREY:ATBPF - Post by User
Comment by
MrMugsyon Feb 14, 2021 1:54pm
165 Views
Post# 32565077
RE:Our platform is an iceberg and we are only seeing the tip !
RE:Our platform is an iceberg and we are only seeing the tip ! Goaweigh wrote: I'm fascinated by the potential of this drug platform and how it might impact people with IBD.
Remember reading a paper co authored by Dr. Wallace in collaboration with another Dr. in Edmonton or Calgary, can't remember now, but they had done some work with H2S on IBD with significant results I believe.
I read somewhere that IBD effects 3,000,000 people in NA so that is a huge market. It doesn't compare to the sheer numbers of people who take NSAIDS every day but the dollars per pill for an NSAID will be pretty low while the dollars of revenue for a disease like IBD would be huge.
We could have a cure and that is significant, if only $ 1000 per person per year, which isn't that much given the benefits, that's a $ 3 Billion drug. Could be much higher.
Don't know the multiple on sales/revenue on a blockbuster drug like that but I believe that's where our real value lies....hidden beneath the surface and the success of ATB-346 will help reveal what's really here !
We had 2 drugs for IBD ... ATB-428 and ATB-429.
They really don't talk to these drugs anymore.
https://antibethera.com/news/calgary-researchers-discover-a-novel-approach-to-treatment-of-inflammatory-bowel-diseases-ibd-using-hydrogen-sulfide-technology/ Not sure what the priority of the new IBD drug is or if it only gets advanced if it is acquired or partnered in some collaboration.
Curious what they're thinking at ATE.